Silence Therapeutics - Wikipedia
Summary
Silence Therapeutics is a London-based biopharmaceutical company founded in 1994. It develops siRNA therapeutics that use RNA interference to silence disease-related genes. The company focuses on rare diseases and cardiovascular risk, including candidates such as SLN124 and zerlasiran. It also maintains offices in New Jersey and Berlin and works with partners such as AstraZeneca, Mallinckrodt Pharmaceuticals, and Hansoh Pharma.
Classifications
industries
Fintech & Banking
applications
Governance, risk and compliance
AskAI Classifications
Labels
Financial Technology
SaaS
Data Analytics Software
Linked Companies
Nasdaq, Inc.
$5M to $10M